BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38684862)

  • 1. GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice.
    Milani M; Canepari C; Assanelli S; Merlin S; Borroni E; Starinieri F; Biffi M; Russo F; Fabiano A; Zambroni D; Annoni A; Naldini L; Follenzi A; Cantore A
    EMBO Mol Med; 2024 Jun; 16(6):1427-1450. PubMed ID: 38684862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
    Kang Y; Xie L; Tran DT; Stein CS; Hickey M; Davidson BL; McCray PB
    Blood; 2005 Sep; 106(5):1552-8. PubMed ID: 15886327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro.
    Schauber CA; Tuerk MJ; Pacheco CD; Escarpe PA; Veres G
    Gene Ther; 2004 Feb; 11(3):266-75. PubMed ID: 14737086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.
    Matsui H; Hegadorn C; Ozelo M; Burnett E; Tuttle A; Labelle A; McCray PB; Naldini L; Brown B; Hough C; Lillicrap D
    Mol Ther; 2011 Apr; 19(4):723-30. PubMed ID: 21285959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery to airway epithelial cells in vivo: a direct comparison of apical and basolateral transduction strategies using pseudotyped lentivirus vectors.
    Kremer KL; Dunning KR; Parsons DW; Anson DS
    J Gene Med; 2007 May; 9(5):362-8. PubMed ID: 17380490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII gene.
    Staber JM; Pollpeter MJ; Anderson CG; Burrascano M; Cooney AL; Sinn PL; Rutkowski DT; Raschke WC; McCray PB
    Gene Ther; 2017 Nov; 24(11):742-748. PubMed ID: 28905885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice.
    Park F
    Hum Gene Ther; 2003 Oct; 14(15):1489-94. PubMed ID: 14577928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
    Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
    Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient production of human FVIII in hemophilic mice using lentiviral vectors.
    Kootstra NA; Matsumura R; Verma IM
    Mol Ther; 2003 May; 7(5 Pt 1):623-31. PubMed ID: 12718905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
    Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
    Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraosseous delivery of lentiviral vectors targeting factor VIII expression in platelets corrects murine hemophilia A.
    Wang X; Shin SC; Chiang AF; Khan I; Pan D; Rawlings DJ; Miao CH
    Mol Ther; 2015 Apr; 23(4):617-26. PubMed ID: 25655313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.
    Trobridge GD; Wu RA; Hansen M; Ironside C; Watts KL; Olsen P; Beard BC; Kiem HP
    Mol Ther; 2010 Apr; 18(4):725-33. PubMed ID: 19997089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDĪ³c
    Levy C; Fusil F; Amirache F; Costa C; Girard-Gagnepain A; Negre D; Bernadin O; Garaulet G; Rodriguez A; Nair N; Vandendriessche T; Chuah M; Cosset FL; Verhoeyen E
    J Thromb Haemost; 2016 Dec; 14(12):2478-2492. PubMed ID: 27685947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.
    Kang Y; Stein CS; Heth JA; Sinn PL; Penisten AK; Staber PD; Ratliff KL; Shen H; Barker CK; Martins I; Sharkey CM; Sanders DA; McCray PB; Davidson BL
    J Virol; 2002 Sep; 76(18):9378-88. PubMed ID: 12186920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
    Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
    Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64.
    Kumar M; Bradow BP; Zimmerberg J
    Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a third generation lentiviral vector pseudotyped with Nipah virus envelope proteins for endothelial cell transduction.
    Witting SR; Vallanda P; Gamble AL
    Gene Ther; 2013 Oct; 20(10):997-1005. PubMed ID: 23698741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses.
    Kitagawa Y; Tani H; Limn CK; Matsunaga TM; Moriishi K; Matsuura Y
    J Virol; 2005 Mar; 79(6):3639-52. PubMed ID: 15731258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain.
    Markusic DM; van Til NP; Hiralall JK; Elferink RP; Seppen J
    BMC Biotechnol; 2009 Oct; 9():85. PubMed ID: 19811629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Platform for Immune Tolerance Induction in Hemophilia A Mice.
    Merlin S; Cannizzo ES; Borroni E; Bruscaggin V; Schinco P; Tulalamba W; Chuah MK; Arruda VR; VandenDriessche T; Prat M; Valente G; Follenzi A
    Mol Ther; 2017 Aug; 25(8):1815-1830. PubMed ID: 28552407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.